[1] Lizaola B, Bonder A, Trivedi HD. et al. Review article: the diagnostic approach and current mAanagement of chylous ascites. Aliment Pharmacol Ther, 2017:1-9.
[2] 吕超,王雨田.肝硬化乳糜性腹水治疗进展.国际消化病杂志, 2008, 28:106-108.
[3] Kumar KS, Lee WM. Chylous ascites with marked elevation of CA-125 in cirrhosis. Am J Gastroenterol,2000,95:3313-3314.
[4] Leibovitch I, Mor Y, Golomb J, et al. The diagnosis and management of postoperative chylous ascites. J Urol,2002,167:449.
[5] Suarez Crespo JF, De Sola Earle C, Quintero Fuentes D, et al. Chylous ascites associated to liver cirrhosis treated with medium-chain triglycerides. Rev Esp Enferm Dig,1995,87:834.
[6] Ilhan E, Demir U, Alemdar A, et al. Management of high-output chylous ascites after D2-lymphadenect-omy in patients with gastric cancer: a multi-center study. J Gastrointestinal Oncol, 2016,7:420-425.
[7] Berzigotti A, Magalotti D, Cocci C, et al. Octreotide in the outpatient theraphy of cirrhotic chylous ascites: A case report. Dig Liver Dis, 2006,38:138-142. |
